We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRandomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.AuthorsKhuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WKPublicationJournal of the National Cancer Institute, 2006, Vol 98, Issue 7, p441ISSN1460-2105Publication typearticleDOI10.1093/jnci/djj091